Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Analysis
Comment
Deals
Events
News
People

Page 2

Codiak revokes $86m IPO filing
Codiak Biosciences has withdrawn its proposed offering citing unfavourable market conditions, delaying an exit for investors including Alexandria Real Estate Equities.
Morphic takes more money in $104m IPO
The corporate-backed small molecule therapeutic developer has boosted its initial public offering from $90m to nearly $104m.
Livongo gives $100m IPO a go
Health management app developer Livongo Health was valued at $800m as of 2018, and a range of corporate investors could exit in the offering.
Health Catalyst puts IPO plans in motion
UPMC and Kaiser Permanente are both in line for exits after health data platform developer Health Catalyst filed for a $100m initial public offering.
Karuna kicks its way into public markets
PureTech Health-backed neuropsychiatric drug developer Karuna Therapeutics raised $89.2m in an upsized offering that followed $123m in venture capital.
BridgeBio crosses over to public markets with $349m
AIG scored an exit as genetic disease and cancer drug developer BridgeBio Pharma floated above its range while increasing the number of shares in its IPO.
Adaptive Biotechnologies shapes $300m IPO
Shares in Adaptive Biotechnologies, backed by Microsoft, Celgene, Illumina, LabCorp and BD Biosciences, soared more than 100% on its first day of trading.
The RealReal realises IPO plans in $300m offering
Novel Group-backed luxury goods marketplace The RealReal will raise $300m in an initial public offering in which it will float above its range.
Morphic shapes $90m initial public offering
Morphic began trading on the Nasdaq Global Market yesterday after issuing 6 million shares priced at $15 each, providing exits to AbbVie, GSK, Novo, Pfizer, Schrödinger and ShangPharma.
Mirum takes a run at public markets
Shire and Novo are in line for exits from liver disease startup Mirum Pharmaceuticals, which has filed to raise $86.3m in its IPO.

test reg

Login